by Gary Finnegan: A superbug present in hospitals across Europe and the US can become resistant to treatment even without undergoing genetic changes, according to a new study… read more.
by Gary Finnegan: A superbug present in hospitals across Europe and the US can become resistant to treatment even without undergoing genetic changes, according to a new study… read more.
by Gary Finnegan: The number of new medicines for rare diseases approved by EU drug regulators hit a record high in 2014. Of the 82 medicines given the… read more.
by Gary Finnegan: The European Medicines Agency (EMA) is to step up international cooperation on regulating generics. The regulator says it is ready to share assessment reports for… read more.
by Gary Finnegan: An electronic repository for periodic safety update reports (PSURs) and their assessment reports has been launched by the European Medicines Agency (EMA).
Pain, discomfort and magnet displacement were documented in a small medical records review study of patients with cochlear implants (CIs) who underwent magnetic resonance imaging (MRI), according to… read more.
by Gary Finnegan: Seven new medicines have approved at the January meeting of the Committee for Medicinal Products for Human Use (CHMP) – the European Medicines Agency’s influential… read more.
Results of treating shoulder pain in throwing athletes are not as predictable as doctors, patients and coaches would like to think, according to a report in the journal Physical… read more.
An international research group with members from the University of Basel, several EU countries, Israel and the USA, analyzed patient satisfaction with pain treatment after surgery.
Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell’s palsy, according to a new study.
by Bruce Sylvester: Vitamin D supplementation appears to lower the incidence of COPD (chronic obstructive pulmonary disease) lung disease flare-up by over 40% in patients with a vitamin… read more.
by Bruce Sylvester: Post-surgical nonsteroidal anti-inflammatory drug (NSAID) therapy appears to entail an increased risk of anastomotic leak at the surgical junction among patients who have undergone non-elective… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
